The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...
Accelerate Diagnostics (AXDX) announced the submission of its Accelerate WAVE system and positive blood culture gram-negative test kit to the ...
The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...
Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results